{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:34:59Z","timestamp":1790271299600,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012292","name":"Working Dog Centre, Massey University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006307","name":"Administration for Community Living","doi-asserted-by":"publisher","award":["CMS"],"award-info":[{"award-number":["CMS"]}],"id":[{"id":"10.13039\/100006307","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1053\/j.gastro.2019.06.014","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T20:31:15Z","timestamp":1564086675000},"page":"859-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)"],"prefix":"10.1053","volume":"157","author":[{"given":"Alonso","family":"Carrasco-Labra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubov","family":"Lytvyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Surawicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Chey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2019.06.014_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ajg.2010.47","article-title":"Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts","volume":"105","author":"Spiegel","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2019.06.014_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1053\/j.gastro.2014.09.001","article-title":"American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome","volume":"147","author":"Weinberg","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11894-009-0039-x","article-title":"The burden of IBS: looking at metrics","volume":"11","author":"Spiegel","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1053\/j.gastro.2019.06.014_bib6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1572-0241.2001.03789.x","article-title":"Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors","volume":"96","author":"Koloski","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/j.gastro.2009.01.015","article-title":"Burden of digestive diseases in the United States part II: lower gastrointestinal diseases","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gtc.2010.12.013","article-title":"The effect of irritable bowel syndrome on health-related quality of life and health care\u00a0expenditures","volume":"40","author":"Agarwal","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2019.06.014_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/apt.13283","article-title":"Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel\u00a0syndrome with symptoms, biomarkers and\/or psychological markers","volume":"42","author":"Sood","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2019.06.014_bib10","first-page":"S1","article-title":"An evidence-based position statement on the management of irritable bowel syndrome","volume":"104","author":"Brandt","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib11","article-title":"Bowel disorders","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gut.2008.159723","article-title":"Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis","volume":"57","author":"Ford","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2019.06.014_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ajg.2015.117","article-title":"Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care","volume":"110","author":"Ford","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/apt.13846","article-title":"Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care","volume":"45","author":"Simpkins","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib16","first-page":"704","article-title":"Update on the incidence and prevalence of inflammatory bowel disease in the United States","volume":"12","author":"Loftus","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1053\/j.gastro.2019.06.014_bib17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib18","first-page":"1","article-title":"NIH Consensus Development Conference on Celiac\u00a0Disease","volume":"21","year":"2004","journal-title":"NIH Consens State Sci Statements"},{"key":"10.1053\/j.gastro.2019.06.014_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.163.3.286","article-title":"Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study","volume":"163","author":"Fasano","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2019.06.014_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2019.06.014_bib21","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J\u00a0Stat Softw"},{"key":"10.1053\/j.gastro.2019.06.014_bib22","series-title":"R: A language and environment for Statistical Computing","year":"2016"},{"key":"10.1053\/j.gastro.2019.06.014_bib23","author":"Doebler"},{"key":"10.1053\/j.gastro.2019.06.014_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"Bmj"},{"key":"10.1053\/j.gastro.2019.06.014_bib25","series-title":"GRADEpro GDT: GRADEpro Guideline Development Tool [software]","year":"2015"},{"key":"10.1053\/j.gastro.2019.06.014_bib26","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1572-0241.2007.01173.x","article-title":"Detection of celiac disease in primary care: A multicenter case-finding study in North America","volume":"102","author":"Catassi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00365529850172043","article-title":"Identification of coeliac disease in primary care","volume":"33","author":"Dickey","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/2277-9175.156647","article-title":"Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome","volume":"4","author":"Kalantari","year":"2015","journal-title":"Advanced Biomedical Research"},{"key":"10.1053\/j.gastro.2019.06.014_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tmaid.2014.05.001","article-title":"Distinguishing tropical sprue from celiac disease in returning travellers with chronic diarrhoea: a diagnostic challenge?","volume":"12","author":"Langenberg","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1053\/j.gastro.2019.06.014_bib30","first-page":"1275","article-title":"Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. [Erratum appears in Clin Chem Lab Med. 2008;46(12):1798]","volume":"46","author":"Otten","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.gastro.2019.06.014_bib31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s10620-005-2576-y","article-title":"Serologic testing for celiac disease in young adults\u2014a cost-effect analysis","volume":"50","author":"Yagil","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2019.06.014_bib32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10534-014-9745-4","article-title":"Fecal lactoferrin and intestinal permeability are effective non-invasive markers in the diagnostic work-up of chronic diarrhea","volume":"27","author":"Caccaro","year":"2014","journal-title":"BioMetals"},{"key":"10.1053\/j.gastro.2019.06.014_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1373\/49.6.861","article-title":"Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children","volume":"49","author":"Carroccio","year":"2003","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2019.06.014_bib34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/clinchem\/48.9.1546","article-title":"Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a\u00a0prospective study","volume":"48","author":"Carroccio","year":"2002","journal-title":"Clinical Chemistry"},{"key":"10.1053\/j.gastro.2019.06.014_bib35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1053\/j.gastro.2011.06.084","article-title":"The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls","volume":"141","author":"Cash","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3109\/00365521.2014.934913","article-title":"Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders","volume":"49","author":"Caviglia","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1590-8658(03)00381-5","article-title":"Role of faecal calprotectin as non-invasive marker of intestinal inflammation","volume":"35","author":"Costa","year":"2003","journal-title":"Digest Liver Dis"},{"key":"10.1053\/j.gastro.2019.06.014_bib38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00042737-199706000-00002","article-title":"Association between serum levels of total IgA and IgA class endomysial and antigliadin antibodies: implications for coeliac disease screening","volume":"9","author":"Dickey","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2036.2004.02128.x","article-title":"Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology","volume":"20","author":"Dolwani","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-147-5-200709040-00003","article-title":"Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease","volume":"147","author":"Hadithi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2019.06.014_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.39133.668681.BE","article-title":"Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool","volume":"334","author":"Hopper","year":"2007","journal-title":"Bmj"},{"key":"10.1053\/j.gastro.2019.06.014_bib42","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/gut.2006.113431","article-title":"Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome","volume":"56","author":"Kaiser","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2019.06.014_bib43","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1572-0241.2003.07458.x","article-title":"Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation","volume":"98","author":"Kane","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices","volume":"103","author":"Langhorst","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1053\/j.gastro.2019.06.014_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126438","article-title":"Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects","volume":"10","author":"Pimentel","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2019.06.014_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00042737-200204000-00013","article-title":"A\u00a0new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders","volume":"14","author":"Poullis","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2008.03797.x","article-title":"Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and\u00a0ELISA methods","volume":"28","author":"Rashtak","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ibd.20275","article-title":"Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies","volume":"14","author":"Schoepfer","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2019.06.014_bib49","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1365-2036.2007.03457.x","article-title":"Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of\u00a0calprotectin","volume":"26","author":"Schroder","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2036.2003.01666.x","article-title":"Coeliac disease presenting with symptoms of irritable bowel syndrome","volume":"18","author":"Shahbazkhani","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(85)90219-0","article-title":"C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders","volume":"148","author":"Shine","year":"1985","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.gastro.2019.06.014_bib52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2036.2010.04306.x","article-title":"Faecal lactoferrin\u2014a novel test to differentiate between the irritable and\u00a0inflamed bowel?","volume":"31","author":"Sidhu","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib53","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1046\/j.1365-2036.2003.01595.x","article-title":"Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies","volume":"17","author":"Tesei","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib54","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.47.4.506","article-title":"A\u00a0simple method for assessing intestinal inflammation in Crohn's disease","volume":"47","author":"Tibble","year":"2000","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2019.06.014_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02208588","article-title":"Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults","volume":"41","author":"Valdimarsson","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2019.06.014_bib56","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cgh.2007.03.021","article-title":"Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome","volume":"5","author":"Wahnschaffe","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1258\/000456304323019613","article-title":"Faecal calprotectin: a new marker for Crohn's disease?","volume":"41","author":"Wassell","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"10.1053\/j.gastro.2019.06.014_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3892\/mmr.2014.2180","article-title":"Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome","volume":"10","author":"Chang","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1053\/j.gastro.2019.06.014_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.290.6469.665","article-title":"Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention","volume":"290","author":"Merrick","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.gastro.2019.06.014_bib60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00535-011-0516-5","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity","volume":"47","author":"Oikonomou","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0016-5085(86)90431-2","article-title":"Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with illeal dysfunction or diarrhea","volume":"91","author":"Sciarretta","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib62","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gut.28.8.970","article-title":"75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit","volume":"28","author":"Sciarretta","year":"1987","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2019.06.014_bib63","first-page":"236","article-title":"Clinical experience with the use of anti-CdtB and anti-vinculin antibodies in patients with diarrhea in Mexico","volume":"81","author":"Schmulson","year":"2016","journal-title":"Rev Gastroenterol Mexico"},{"key":"10.1053\/j.gastro.2019.06.014_bib64","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/gutjnl-2015-309889","article-title":"Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis","volume":"65","author":"Valentin","year":"2016","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2019.06.014_bib65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mimet.2016.08.017","article-title":"Giardiasis: an update review on sensitivity and specificity of methods for laboratorial diagnosis","volume":"129","author":"Soares","year":"2016","journal-title":"J\u00a0Microbiol Methods"},{"key":"10.1053\/j.gastro.2019.06.014_bib66","series-title":"Procedures for the Recovery and Identification of parasites From the Intestinal Tract; Approved Guideline. CLSI document M28-A2","year":"2005"},{"key":"10.1053\/j.gastro.2019.06.014_bib67","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.02877-13","article-title":"Detection of intestinal protozoa in the clinical laboratory","volume":"52","author":"McHardy","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1053\/j.gastro.2019.06.014_bib68","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib69","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A\u00a0meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib70","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.2017.1462","article-title":"Screening for celiac disease: US Preventive Services Task Force Recommendation Statement","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2019.06.014_bib71","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1053\/j.gastro.2005.02.014","article-title":"The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review","volume":"128","author":"Dube","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2009.03.059","article-title":"Increased prevalence and mortality in undiagnosed celiac disease","volume":"137","author":"Rubio-Tapia","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.06.014_bib73","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/bmj.38169.486701.7C","article-title":"Malignancy and mortality in people with coeliac disease: population based cohort study","volume":"329","author":"West","year":"2004","journal-title":"Bmj"},{"key":"10.1053\/j.gastro.2019.06.014_bib74","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MCG.0b013e31827a6f83","article-title":"World Gastroenterology Organisation global guidelines on celiac disease","volume":"47","author":"Bai","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib76","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MPG.0000000000001216","article-title":"NASPGHAN Clinical Report on the Diagnosis and Treatment of Gluten-Related Disorders","volume":"63","author":"Hill","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2019.06.014_bib77","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1373\/clinchem.2008.103606","article-title":"Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic","volume":"54","author":"McGowan","year":"2008","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2019.06.014_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13227","article-title":"Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea","volume":"42","author":"Slattery","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib79","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cgh.2013.04.029","article-title":"Methods for diagnosis of bile acid malabsorption in clinical practice","volume":"11","author":"Vijayvargiya","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib80","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/apt.13570","article-title":"Review article: bile acid diarrhoea\u2014pathogenesis, diagnosis and management","volume":"43","author":"Mottacki","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.06.014_bib81","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1038\/ctg.2012.10","article-title":"Fibroblast growth factor 19 and 7alpha-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea","volume":"3","author":"Pattni","year":"2012","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib82","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1139\/w2012-039","article-title":"Nonutility of routine testing of stool for ova and parasites in a tertiary care Canadian centre","volume":"58","author":"Mosli","year":"2012","journal-title":"Can J Microbiol"},{"key":"10.1053\/j.gastro.2019.06.014_bib83","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1099\/jmm.0.000558","article-title":"Evaluation of the BD MAX Enteric Parasite Panel for the detection of Cryptosporidium parvum\/hominis, Giardia duodenalis and Entamoeba histolytica","volume":"66","author":"Perry","year":"2017","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1053\/j.gastro.2019.06.014_bib84","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s10620-007-9977-z","article-title":"A\u00a0new rat model links two contemporary theories in irritable bowel syndrome","volume":"53","author":"Pimentel","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2019.06.014_bib85","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ajg.2016.477","article-title":"Diagnosis and management of microscopic colitis","volume":"112","author":"Pardi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib86","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/MEG.0000000000000365","article-title":"The yield of colonic biopsy in the evaluation of chronic unexplained diarrhea","volume":"27","author":"Genta","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib87","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cgh.2015.09.031","article-title":"Irritable bowel syndrome and microscopic colitis: a systematic review and meta-analysis","volume":"14","author":"Kamp","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.06.014_bib88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-230X-13-80","article-title":"Low prevalence of \u2018classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea","volume":"13","author":"Hilmi","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-230X-11-96","article-title":"The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome","volume":"11","author":"Ozdil","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2019.06.014_bib90","first-page":"133","article-title":"Prevalence of microscopic colitis in patients with symptoms suggesting irritable bowel syndrome","volume":"66","author":"Tuncer","year":"2003","journal-title":"Acta Gastroenterol Belg"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2019.06.014_bib91","first-page":"103","article-title":"Ileocolorectal inflammation and psychopathological status in patients with diarrhea-predominant functional bowel disorders","volume":"24","author":"Cantarini","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.gastro.2019.06.014_bib92","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ajg.2010.55","article-title":"The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial","volume":"105","author":"Chey","year":"2010","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519410123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519410123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:21:42Z","timestamp":1758036102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508519410123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0016508519410123"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2019.06.014","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2019.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}